Skip to Content

WATSON 408 (Lisinopril 20 mg)

Pill with imprint WATSON 408 is Yellow, Round and has been identified as Lisinopril 20 mg. It is supplied by Watson Pharmaceuticals.

Lisinopril is used in the treatment of diabetic kidney disease; heart attack; high blood pressure; heart failure and belongs to the drug class Angiotensin Converting Enzyme Inhibitors. There is positive evidence of human fetal risk during pregnancy. Lisinopril 20 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WATSON 408

Lisinopril

Imprint
WATSON 408
Strength
20 mg
Color
Yellow
Size
8.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Angiotensin converting enzyme inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Pharmaceuticals
Inactive Ingredients
silicon dioxide, calcium phosphate dihydrate dibasic, FD&C Yellow No. 5, magnesium stearate, mannitol, corn starch

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00591-0408 Watson Pharmaceuticals, Inc.
63739-0350 McKesson Packaging Services
43063-0007 PDRX Pharmaceuticals Inc. (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.